Endonovo Therapeutics Inc (ENDV)

[sello]

They will probably update when they release the 10-q, which should be this week.

Several people that have been in touch with the new IR guy said he was anticipating this 10-q to be a catalyst. Hard to believe we will see much in revenue yet, considering it will only reflect 2 months from the initials sales to end of quarter. Maybe the have progressed with funding through the preferred offering?

Looks like they allowed the first loan with Eagle to convert out. With the payment of $210k on April 7th and after converting $50k per week for the last 8 months, that loan should be coming to a point of final conversion. I would think Eagle may want on to hold that final block for a while. Wonder if there is a correlation between OTCX's constant push down for the last 3 months, seeming disappearance, and a final conversion?

The next loan with Eagle can begin conversions June 26th. ENDV can make cash payments in $50k installments before conversion, and the pay off interest is 15% less than terms of the first loan.

I was hoping to see the HDE application filed with time to possibly get approval before that note was eligible for conversion. With the plan of getting initial approval for Lyme disease and then adding extensions for the other treatments, i.e. stroke, MS, concussion, kidney, etc. The approval would be a huge green flag for getting multiple applications to market in a very fast time frame and I would imagine be very attractive to larger investors.

....and we wait...